C4 Therapeutics, Inc. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (5)
- Human Resources (6)
- Intellectual Property (3)
- Real Estate (2)
- Uncategorized (1)
- License and Collaboration Agreement, dated (Filed With SEC on May 30, 2023)
- Stock Purchase Agreement, dated (Filed With SEC on May 30, 2023)
- 2020 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on February 23, 2023)
- Lease Amendment, dated November 24, 2021, by and between C4 Therapeutics, Inc. and Columbia Massachusetts Arsenal Office Properties, LLC (Filed With SEC on November 30, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 14, 2021)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 11, 2021)
- Amendment No. 1 to Collaborative Research and License Agreement between the Registrant and Biogen MA, Inc., dated February 25, 2020 (Filed With SEC on March 11, 2021)
- First Amendment to the Amended and Restated License Agreement among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated November 12, 2020 (Filed With SEC on March 11, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 28, 2020)
- Form of Specimen Common Stock Certificate (Filed With SEC on September 28, 2020)
- 2020 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on September 28, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 28, 2020)
- Amended and Restated Investors Rights Agreement among the Registrant, its warrant holder and certain of its stockholders, dated June 5, 2020 (Filed With SEC on September 10, 2020)
- Warrant Certificate issued by the Registrant to Perceptive Credit Holdings III, LP dated June 5, 2020 (Filed With SEC on September 10, 2020)
- 2015 Stock Option and Grant Plan, as amended and forms of award agreements thereunder (Filed With SEC on September 10, 2020)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on September 10, 2020)
- Form of Director Indemnification Agreement (Filed With SEC on September 10, 2020)
- Form of Officer Indemnification Agreement (Filed With SEC on September 10, 2020)
- Form of Executive Officer Employment Agreement (Filed With SEC on September 10, 2020)
- Employment Agreement between the Registrant and Andrew Hirsch, dated September 6, 2020 (Filed With SEC on September 10, 2020)
- Consulting Agreement between the Registrant and MBJC Associates, LLC, effective March 31, 2020 (Filed With SEC on September 10, 2020)
- Collaboration Research and License Agreement between the Registrant and Biogen MA, Inc., dated December 28, 2018 (Filed With SEC on September 10, 2020)
- Amended and Restated License Agreement among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated December 20, 2018 (Filed With SEC on September 10, 2020)
- Collaboration and License Agreement between the Registrant and Calico Life Sciences LLC, dated March 13, 2017 (Filed With SEC on September 10, 2020)
- Credit Agreement and Guaranty among the Registrant, Perceptive Credit Holdings III, LP and the guarantors and lenders party thereto, dated July 5, 2020 (Filed With SEC on September 10, 2020)
- Lease by 480 Arsenal Group LLC to the Registrant, dated July 5, 2017, as amended (Filed With SEC on September 10, 2020)
